Effective microorganism fermentation extract (EM-X) attenuates airway hyperreactivity and inflammation through selective inhibition of the TH2 response independently of antioxidant activity

International Journal of Molecular Medicine

Volumn 20, Issue 4, 2007, Pages 631-635

  Do, Jeong Su ^a   Seo, Hyo Jung ^a   Hwang, Jin Ki ^a   Kim, Jun Hee ^a   Nam, Sang Yun ^a  

^a Jeonu University   (South Korea)

Author keywords

Airway hyperreactivity; Cytokine; Effective microorganism fermentation extract; Inflammation; TH2 response

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ANTIASTHMATIC AGENT; ANTIGEN; ANTIOXIDANT; DRUG DERIVATIVE; IMMUNOGLOBULIN; MICROORGANISM FERMENTATION EXTRACT; PLANT EXTRACT; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; DISEASE MODEL; DRUG EFFECT; FEMALE; IMMUNOLOGY; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG LAVAGE; LYMPH NODE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; TH2 CELL;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIGENS; ANTIOXIDANTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; DINOPROST; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULINS; INFLAMMATION; LUNG; LYMPH NODES; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; TH2 CELLS;

EID: 38449120293     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.4.631     Document Type: Article

References (38)

1. ISAAC: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema; ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351: 1225-1232, 1998.
2. Umetsu DT, McIntire JJ, Akbari O, Macaubas C and DeKruyff RH: Asthma: an epidemic of dysregulated immunity. Nat Immunol 3: 715-720, 2002.
3. Maddox L and Schwartz DA: The pathophysiology of asthma. Annu Rev Med 53: 477-498, 2002.
4. Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17: 255-281, 1999.
5. Coyle AJ, Le Gros G, Bertrand C, et al: Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 13: 54-59, 1995.
6. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 10: 587-593, 1994.
7. Hogan SP, Koskinen A and Foster PS: Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 75: 284-288, 1997.
8. Henderson WR Jr, Chi EY and Maliszewski CR: Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol 164: 1086-1095, 2000.
9. Hamelmann E, Oshiba A, Loader J, et al: Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 155: 819-825, 1997.
10. Broide DH, Paine MM and Firestein GS: Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90: 1414-1424, 1992.
11. Desreumaux P, Janin A, Dubucquoi S, et al: Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82: 1553-1560, 1993.
12. Woerly G, Lacy P, Younes AB, et al: Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol 72: 769-779, 2002.
13. Bandeira-Melo C, Sugiyama K, Woods LJ and Weller PF: Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol 166: 4813-4817, 2001.
14. Liu Z, Liu Q, Hamed H, et al: IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites. J Immunol 174: 2242-2249, 2005.
15. Xu WF, Ji YY, Wu YD, Lin GM, Ye M and Sun B: Roles of IL-4 and other factors in the trichosanthin-induced ovalbumin-specific IgE response. Acta Pharmacol Sin 22: 736-740, 2001.
16. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG and Vadas MA: Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167: 219-224, 1988.
17. Clutterbuck EJ, Hirst EM and Sanderson CJ: Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 73: 1504-1512, 1989.
18. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI and Young IG: Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201, 1996.
19. Huang SK, Xiao HQ, Kleine-Tebbe J, et al: IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155: 2688-2694, 1995.
20. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H and Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245-248, 1993.
21. McKenzie GJ, Emson CL, Bell SE, et al: Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9: 423-432, 1998.
22. Rahman I, Morrison D, Donaldson K and MacNee W: Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154: 1055-1060, 1996.
23. Henricks PA and Nijkamp FP: Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 14: 409-420, 2001.
24. Higa T and Ke B: Clinical and basic medical research on EMX. EMRO Okinawa, 2001.
25. Chui CH, Cheng GY, Ke B, et al: Growth inhibitory potential of effective microorganism fermentation extract (EM-X) on cancer cells. Int J Mol Med 14: 925-929, 2004.
26. Aruoma OI, Deiana M, Rosa A, et al: Assessment of the ability of the antioxidant cocktail-derived from fermentation of plants with effective microorganisms (EM-X) to modulate oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of poly- and mono-unsaturated fatty acids. Toxicol Lett 135: 209-217, 2002.
27. Deiana M, Dessi MA, Ke B, et al: The antioxidant cocktail effective microorganism X (EM-X) inhibits oxidant-induced interleukin-8 release and the peroxidation of phospholipids in vitro. Biochem Biophys Res Commun 296: 1148-1151, 2002.
28. Aruoma OI, Moncaster JA, Walsh DT, et al: The antioxidant cocktail, effective microorganism X (EM-X), protects retinal neurons in rats against N-methyl-D-aspartate excitotoxicity in vivo. Free Radic Res 37: 91-97, 2003.
29. Datla KP, Bennett RD, Zbarsky V, et al: The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. J Pharm Pharmacol 56: 649-654, 2004.
30. Yuan HC: EM-X as a free radical scavenger. Center for Condensed Matter Science, National Taiwan University, Taipei, 1999.
31. Hamelmann E, Schwarze J, Takeda K, et al: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156: 766-775, 1997.
32. Baraldi E, Ghiro L, Piovan V, et al: Increased exhaled 8-isoprostane in childhood asthma. Chest 124: 25-31, 2003.
33. Committee IEMCE: Proceedings of The 2nd International EM Medical Conference. IEMC Executive Committee Secretariat, Okinawa, 2003.
34. Wood LG, Garg ML, Simpson JL, et al: Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med 171: 426-430, 2005.
35. Walker C, Virchow JC Jr, Bruijnzeel PL and Blaser K: T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 146: 1829-1835, 1991.
36. Robinson DS, Hamid Q, Ying S, et al: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298-304, 1992.
37. Rowe BH, Edmonds ML, Spooner CH, Diner B and Camargo CA Jr: Corticosteroid therapy for acute asthma. Respir Med 98: 275-284, 2004.
38. Nimmagadda SR, Spahn JD, Nelson HS, Jenkins J, Szefler SJ and Leung DY: Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma. Ann Allergy Asthma Immunol 81: 35-40, 1998.